Arrhythmogenic right ventricular cardiomyopathy and sports activity: Figure 1
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
This editorial refers to ‘Association of competitive and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy: results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiomyopathy’†, by A.C. Ruwald et al., on page 1735. Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited heart muscle disease characterized by ventricular electrical instability which may lead to arrhythmic cardiac arrest, mostly in young people and athletes.1 Molecular genetics studies have provided significant insights towards our understanding of the pathogenesis of ARVC, showing that it is a genetic disorder resulting from defective desmosomal proteins.2 The pathological hallmark of the disease is the progressive loss of myocardium with subsequent myocyte death and fibrofatty scar which predisposes to life-threatening ventricular arrhythmias.3 Competitive sports activity increases the risk of sudden cardiac death (SCD) by five-fold in adolescent and young adults with ARVC.4 Sports has also been implicated as a factor promoting disease progression and worsening of the arrhythmic substrate (Figure 1). Genetically determined impairment of cell to cell adhesion may lead to myocyte death, especially during mechanical stress that occurs during competitive sports activity.1 Kirchhof et al.5 demonstrated that in heterozygous plakoglobin-deficient mice, endurance training accelerated the development of right ventricular (RV) abnormalities and ventricular arrhythmias. James et al.6 confirmed in humans that endurance sports and frequent exercise increase age-related penetrance, risk of ventricular tachyarrhythmias, and occurrence of heart failure in ARVC desmosomal gene carriers.1 Schematic representation of the course of arrhythmogenic right ventricular cardiomyopathy from desmosomal gene mutation to phenotypic expression and cardiac arrest due to ventricular fibrillation. Sports activity may promote development of phenotypic expression, accelerate disease progression, and trigger life-threatening ventricular arrhythmias (see text for more details). Early identification of affected patients by preparticipation screening and disqualification from competitive sports activity may prevent SCD. A time-trend analysis of the incidence of SCD in young competitive athletes aged 12–35 years in the Veneto region of Italy demonstrated a 90% decrease of SCD in athletes after the introduction of the nationwide ECG screening programme.7 This mortality reduction was a reflection of a lower incidence of SCD from cardiomyopathies (ARVC and hypertrophic cardiomyopathy), as a result of increasing identification over time of affected athletes at pre-participation screening. Accordingly, there is general consensus that restriction of participation in competitive sports activity can be regarded as a treatment modality of patients with ARVC to reduce the risk of SCD. Expert recommendations for sports eligibility of patients with heart disease focused on those athletes who are engaged in competitive sports.8 However, many young patients with ARVC wish to participate in recreational and leisure time exercise activity, given the recognized beneficial effects of a physically active lifestyle. In this issue of the journal, Ruwald et al.9 provided new and important data on disease presentation and outcomes according to sports participation in 108 ARVC probands with a diagnosis of either definite or borderline ARVC. The authors reported that ARVC patients who were engaged in competitive sports had earlier clinical presentation of the disease, more pronounced RV dilatation/dysfunction, and a greater risk of ventricular tachyarrhythmias/death compared with patients who participated in recreational activities or were inactive. The study demonstrated that the absolute risk of ventricular tachyarrhythmias/death at 40 years after birth was high in patients practising recreational sports (33%) but did not differ significantly from that of physically inactive ARVC patients (22%). Besides adding weight to the previous studies,6,10 the strength of the present study is that it presents new information for recommendations on lifestyle and sports eligibility in patients with ARVC, by providing potentially important reassurance that not all exercise is the same and that patients with ARVC may be able to derive the benefits of leisure time exercise without excess risk. However, the weakness of the study is that its methodology does not provide enough scientific support for recommendations on the level of sports allowed to ARVC patients. A study definition of competitive vs. recreational sports activity was lacking and it was up to the individual patients to assess on the enrolment questionnaire whether they believed that they participate in sports on a competitive or a recreational level or if they defined themselves as inactive. Most importantly, the intensity of the physic
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Corrado, D., Basso, C., Pavei, A., Michieli, P., Schiavon, M., & Thiene, G. (2006) · JAMA · doi:10.1001/jama.296.13.1593 · Cited by 1,559
Self-citationDoes sports activity enhance the risk of sudden death in adolescents and young adults?
Corrado, D., Basso, C., Rizzoli, G., Schiavon, M., & Thiene, G. (2003) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.03.002 · Cited by 1,311 · cited 3×
“Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited heart muscle disease characterized by ventricular electrical instability which may lead to arrhythmic cardiac arrest, mostly in youngpeople andathletes.1 Molecular genetics studieshaveprovided significant insights towards our understanding of the p…”
BackgroundSelf-citationKirchhof, P., Fabritz, L., Zwiener, M., Witt, H., Schäfers, M., Zellerhoff, S., Paul, M., Athai, T., Hiller, K.-H., Baba, H. A., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.624502 · Cited by 429
Bethesda Conference #36 and the European Society of Cardiology Consensus Recommendations Revisited
Pelliccia, A., Zipes, D. P., & Maron, B. J. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.055 · Cited by 295
Lampert, R., Olshansky, B., Heidbuchel, H., Lawless, C., Saarel, E., Ackerman, M., Calkins, H., Estes, N. A. M., Link, M. S., Maron, B. J., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.000447 · Cited by 286
Cited by
Arrhythmogenic Right Ventricular Cardiomyopathy
Corrado, D., Link, M. S., & Calkins, H. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1509267 · Cited by 736
Self-citationZorzi, A., Perazzolo Marra, M., Rigato, I., De Lazzari, M., Susana, A., Niero, A., Pilichou, K., Migliore, F., Rizzo, S., Giorgi, B., et al. (2016) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.116.004229 · Cited by 326
“48,49 Finally, performance-enhancing drugs may induce a variety of rhythm disturbances in the athletes, including VA. 40 However, none of our athletes admitted the use of any drugs, and at present, there is no evidence that illicit substances may cause nonischemic LV scar.”
Self-citationDiagnosis, pathophysiology, and management of exercise-induced arrhythmias
Guasch, E., & Mont, L. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.173 · Cited by 134
Vanaja, I. P., Scalco, A., Ronfini, M., Bona, A. D., Olianti, C., Rizzo, S., Chelko, S. P., Corrado, D., Sacconi, L., Basso, C., et al. (2025) · The Journal of Physiology · doi:10.1113/jp286845 · Cited by 17
Self-citation
Metadata
- Authors
- Corrado, D., & Zorzi, A.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-05-12
- Volume
- 36
- Issue
- 27
- Pages
- 1708-1710
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W1835198200
- Cited by
- 38
- References
- 5
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Arrhythmogenic right ventricular cardiomyopathy and sports activity: Figure 1. https://app.cochat.ai/papers/10.1093/eurheartj/ehv183
- The paper
- Corrado, D., & Zorzi, A. (2015). Arrhythmogenic right ventricular cardiomyopathy and sports activity: Figure 1. European Heart Journal. https://doi.org/10.1093/eurheartj/ehv183
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.